MLAB

Over the past six months (approximately April 2026 to October 2026), Mesa Laboratories' stock has seen significant movement, increasing by 38.71% in the last six months and 18.98% in the past month as of September 10, 2026. As of October 5, 2026, the stock gained 94.1% over the past 12 months, hitting a new 52-week high of $139.60 and closing around $140.90, a 7.4% surge. Key events include strong earnings reports, with the company exceeding analysts' EPS expectations in Q1 2027, Q4 2026, and Q3 2026. Analyst ratings changes have also occurred, with Wall Street Zen upgrading to a "strong-buy," Wells Fargo & Company increasing their target price, and Weiss Ratings upgrading to a "hold." Insider transactions show Director John Sullivan sold shares in August 2026, but overall, insiders have collectively bought more stock than they sold in the past three months. Additionally, Mesa Labs declared a quarterly dividend on July 6, 2026.